Dr Lalchandani Labs Ltd - 541299 - Board Meeting Outcome for Outcome Of The Board Meeting
Outcome of the Board Meeting as held on March 09, 2022.09-03-2022
09-03-2022
Dr Lalchandani Labs Ltd - 541299 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Dr Lalchandani Labs Limited has informed the Exchange regarding Certificate under regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2021.06-01-2022
Dr Lalchandani Labs Ltd - 541299 - Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Swati PoddarDesignation :- Company Secretary and Compliance Officer06-01-2022
Dr Lalchandani Labs Ltd - 541299 - Announcement under Regulation 30 (LODR)-Resignation of Director
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Para A of Part A of Schedule III to the said Regulations, we wish to inform that Ms. Manica Gupta (DIN: 08436144), has submitted her letter of resignation to step down from the position of the Non-Executive Director of the Company from closing of Business hours of dated December 14, 2021 due to their personal reasons.15-12-2021
Dr Lalchandani Labs Ltd - 541299 - Unaudited Financial Results For The Half Year Ended September 30, 2021
We are hereby submitting the Unaudited Financial Results along with Limited Review Report for the half year ended on 30th September, 2021. 1. Un-audited Financial Results for the half year ended on 30th September, 2021. 2. Un-audited Statement of Assets and Liabilities for the half year ended on 30th September, 2021. 3. Cash Flow Statement for the half year ended on 30th September, 2021. 4. Limited Review Report for the half year ended 30th September, 2021.12-11-2021
Dr Lalchandani Labs Ltd - 541299 - Board Meeting Outcome for Outcome Of Board Meeting
We are hereby submitting the Unaudited Financial Results along with Limited Review Report for the half year ended on 30th September, 2021. 1. Un-audited Financial Results for the half year ended on 30th September, 2021. 2. Un-audited Statement of Assets and Liabilities for the half year ended on 30th September, 2021. 3. Cash Flow Statement for the half year ended on 30th September, 2021. 4. Limited Review Report for the half year ended 30th September, 2021.12-11-2021
Dr Lalchandani Labs Ltd - 541299 - Board Meeting Intimation for Board Meeting Intimation For The Board Meeting As Per Regulation 29 Of SEBI(Listing Obligations And Disclosure Requirement) Regulations, 2015
Dr Lalchandani Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, we hereby inform that meeting of Board of Directors has been scheduled to be held on Friday, November 12, 2021 to, inter alia, consider and decide the following business matters: 1. To consider and approve Unaudited Financial Results of the Company for the half year ended September 30, 2021 along with the Limited Review Report. 2. Any other Business matter, with the permission of the Chair.03-11-2021
Dr Lalchandani Labs Ltd - 541299 - Shareholding for the Period Ended September 30, 2021
Dr Lalchandani Labs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here15-10-2021
Dr Lalchandani Labs Ltd - 541299 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Dr Lalchandani Labs Limited has informed the Exchange regarding Certificate under regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2021.15-10-2021
Dr Lalchandani Labs Ltd - 541299 - Statement Of Investor Complaints For The Quarter Ended September 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- SWATI PODDARDesignation :- Company Secretary and Compliance Officer11-10-2021